Role of Endothelium in Doxorubicin-Induced Cardiomyopathy

The clinical use of doxorubicin in cancer is limited by cardiotoxic effects that can lead to heart failure. Whereas earlier work focused on the direct impact of doxorubicin on cardiomyocytes, recent studies have turned to the endothelium, because doxorubicin-damaged endothelial cells can trigger the...

Descripción completa

Detalles Bibliográficos
Autores principales: Luu, Albert Z., Chowdhury, Biswajit, Al-Omran, Mohammed, Teoh, Hwee, Hess, David A., Verma, Subodh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
STATE-OF-THE-ART REVIEW
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314956/
https://www.ncbi.nlm.nih.gov/pubmed/30623145
http://dx.doi.org/10.1016/j.jacbts.2018.06.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314956/
https://www.ncbi.nlm.nih.gov/pubmed/30623145
http://dx.doi.org/10.1016/j.jacbts.2018.06.005

Ejemplares similares